Structural biology of 7SK RNP and its interaction with HIV-1 Tat
7SK RNP 的结构生物学及其与 HIV-1 Tat 的相互作用
基本信息
- 批准号:10402809
- 负责人:
- 金额:$ 47.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalActive SitesBindingBinding ProteinsBinding SitesBiochemicalC-terminalCDK9 Protein KinaseCell MaintenanceComplement Factor BComplexCryoelectron MicroscopyCyclin-Dependent KinasesDiseaseDrug TargetingElongation FactorEnzymesGenetic TranscriptionGoalsHIVHIV-1HealthHeart HypertrophyHumanIn VitroLaboratoriesLeadLinkMessenger RNAMethodsMethylationMolecularMolecular ConformationNMR SpectroscopyPhosphotransferasesPlayPositive Transcriptional Elongation Factor BProteinsRNARNA BindingRNA ConformationRNA Polymerase IIRNA Recognition MotifRNA-Protein InteractionRegulationReportingResistanceRoleSmall Nuclear RibonucleoproteinsStressStructureTrans-ActivatorsTransactivationTranscription ElongationTranscription InitiationTranscriptional RegulationU6 small nuclear RNAUntranslated RNAViralVirus ReplicationWorkX-Ray Crystallographycircular RNAcofactorcyclin T1experimental studyin vivoinorganic phosphateinsightleukemia/lymphomapromoterprotein complexrecruitstoichiometrystructural biologytranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
The human 7SK RNP is a dynamic assembly of the long non-coding 7SK RNA and cellular proteins that
regulates the activity of positive transcription elongation factor b (P-TEFb). P-TEFb is an essential eukaryotic
transcription factor for mRNA transcription elongation, which regulates the transition from promoter proximal
paused RNA polymerase II (RNAPII) into productive elongation. P-TEFb is also an essential human cofactor
for HIV-1 Tat transactivation and therefore viral replication. The human 7SK core RNP comprises the 331 nt
RNAPIII-transcribed non-coding 7SK RNA, an unusual methyl capping enzyme called MePCE that methylates
the γ phosphate on the RNA 5' terminus, and the La related protein 7, Larp7, that associates with the terminal
hairpin and UUU-3'OH. In the active 7SK snRNP, Hexim and P-TEFb, a heterodimer of Cyclin T1 and the
kinase Cdk9, bind the 7SK core RNP; interaction of P-TEFb in this complex inactivates it by sequestering its
active site. Despite the central role of 7SK in transcription regulation of mRNA, other RNAPII RNAs, and HIV-1
transcription, relatively little is known at a structural or mechanistic level about how cellular proteins assemble
with 7SK RNA to form a functional 7SK RNP or how Tat interacts with it to ultimately release P-TEFb. We will
employ a combination of NMR spectroscopy, X-ray crystallography, and cryo electron microscopy along with
biochemical methods to investigate the structures and assembly of the 7SK core RNP (MePCE–7SK–Larp7)
and 7SK core RNP plus Hexim and P-TEFb (the `active' 7SK RNP) in order to achieve an atomic-level
understanding of this important host RNP for HIV-1 viral replication. These structural studies will lay the
groundwork for elucidating the molecular mechanisms of Tat-Hexim competition in the context of 7SK RNP.
We aim to dissect the potential intermediate steps (i.e. Tat-bound 7SK RNP) that lead to P-TEFb hijacking
from 7SK RNP into the HIV-1 viral super-elongation complex. The results of these experiments will provide
fundamental molecular insights into and a structural basis for drug targeting of this largely structurally
uncharacterized RNP that is essential for HIV-1 transcription and therefore escape from latency.
项目摘要/摘要
人7sk RNP是长期非编码7SK RNA和细胞蛋白的动态组装
调节阳性转录伸长因子B(P-TEFB)的活性。 P-TEFB是必不可少的真核生物
mRNA转录伸长的转录因子,调节启动子代理的过渡
暂停的RNA聚合酶II(RNAPII)成生产性延伸。 P-TEFB也是必不可少的人类辅助因子
用于HIV-1 TAT反式激活,因此病毒复制。人7SK核心RNP包括331 nt
rnapiii transcranced非编码7SK RNA,一种称为MEPCE的不寻常的甲基上限酶,该酶是甲基化的
RNA 5'末端上的γ磷酸盐和与末端相关的LA相关蛋白7,LARP7
发夹和uuu-3'oh。在活跃的7SK SNRNP中,Hexim和P-TEFB,Cyclin T1的异二聚体
激酶CDK9,结合7SK Core RNP; P-TEFB在该复合物中的相互作用通过隔离它
活性站点。尽管7SK在mRNA,其他RNAPII RNA和HIV-1中的转录调节中具有中心作用
转录在结构或机械水平上相对较少,以了解细胞蛋白如何组装
使用7SK RNA形成功能性7SK RNP或TAT如何与之相互作用以最终释放P-TEFB。我们将
员工NMR光谱,X射线晶体学和冷冻电子显微镜的组合以及
研究7SK Core RNP的结构和组装的生化方法(MEPCE – 7SK – LARP7)
以及7SK Core RNP加Hexim和P-TEFB(“ Active” 7SK RNP),以实现原子级
了解HIV-1病毒复制的这一重要宿主RNP。这些结构研究将奠定
在7SK RNP的背景下阐明Tat-Hexim竞争的分子机制的基础。
我们旨在剖析导致P-TEFB劫持的潜在中间步骤(即tat-bound 7SK RNP)
从7SK RNP到HIV-1病毒超延长复合物。这些实验的结果将提供
基本的分子见解和靶向该药物的结构性基础在很大程度上在结构上
对HIV-1转录至关重要的未表征的RNP,因此逃脱了潜伏期。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULI FEIGON其他文献
JULI FEIGON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULI FEIGON', 18)}}的其他基金
Structural biology of 7SK RNP and its interaction with HIV-1 Tat
7SK RNP 的结构生物学及其与 HIV-1 Tat 的相互作用
- 批准号:
10170271 - 财政年份:2020
- 资助金额:
$ 47.94万 - 项目类别:
Structural biology of 7SK RNP and its interaction with HIV-1 Tat
7SK RNP 的结构生物学及其与 HIV-1 Tat 的相互作用
- 批准号:
10082693 - 财政年份:2020
- 资助金额:
$ 47.94万 - 项目类别:
CS DOMAIN OF THE ESSENTIAL H/ACA RNP ASSEMBLY PROTEIN SHQ1
必需 H/ACA RNP 组装蛋白 SHQ1 的 CS 结构域
- 批准号:
8169256 - 财政年份:2010
- 资助金额:
$ 47.94万 - 项目类别:
相似海外基金
Development of Selective Oxidative Biocatalytic Methods
选择性氧化生物催化方法的发展
- 批准号:
10606798 - 财政年份:2023
- 资助金额:
$ 47.94万 - 项目类别:
Exploring herpesvirus exonucleases as potential antiviral targets
探索疱疹病毒核酸外切酶作为潜在的抗病毒靶点
- 批准号:
10825475 - 财政年份:2023
- 资助金额:
$ 47.94万 - 项目类别:
Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer
用于研究癌症中 NEK 激酶家族的化学探针的鉴定和表征
- 批准号:
10503430 - 财政年份:2022
- 资助金额:
$ 47.94万 - 项目类别:
Molecular mechanisms for sorting lysosomal proteins
溶酶体蛋白分选的分子机制
- 批准号:
10521596 - 财政年份:2022
- 资助金额:
$ 47.94万 - 项目类别:
Molecular mechanisms for sorting lysosomal proteins
溶酶体蛋白分选的分子机制
- 批准号:
10662534 - 财政年份:2022
- 资助金额:
$ 47.94万 - 项目类别: